Skip to main content
Equibles
HSTM logo

HSTM · Healthstream Inc · Metrics

Track HSTM — free

Use HSTM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HSTM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$33.63 -0.55 (-1.60%) Q2 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$999.42M
Shares
29.24M
Volume · Oct 28 175.71K Avg daily vol (3M) 195.33K

HSTM metrics

104 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$33.73
Market cap
$999.42M

Price action

20 metrics
Price change (1W)
+1.2%
Price change (30D)
+17.3%
Price change (3M)
+18.5%
Price change (6M)
+57.9%
Price change (YTD)
+48.2%
Price change (1Y)
+31.6%
Trailing year
Price change (5Y)
+32.9%
52-week high
$35.16
52-week low
$19.88
Change from 52-week high
-2.8%
Change from 52-week low
+71.9%
Annualized volatility
32.5%
Annualized volatility (3M)
29.1%
Beta
0.2
RSI (14D)
65.9
Price vs SMA 50
+11.6%
Price vs SMA 200
+34.5%
Avg volume (3M)
195,299
Relative volume
0.7
Average dollar volume
$5.88M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
29.24M

Valuation

12 metrics
P / E (TTM)
47.5
Trailing earnings · reciprocal yield 2.1%
PEG ratio
1.7
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.5%
P / book
2.9
reciprocal yield 35.0%
FCF yield
6.9%
TTM · current market cap
Buyback yield
2.1%
P / FCF
14.6
reciprocal yield 6.9%
P / operating cash flow
14.2
reciprocal yield 7.0%
Earnings yield
2.1%

Historical valuation

8 metrics
P / E historical average (3Y)
44.1×
reciprocal yield 2.3%
P / E historical average (5Y)
61.5×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.4%
Trailing 12 months
Payout ratio
18.2%
Shareholder yield
2.5%
Dividend / share (TTM)
$0.14
Dividend growth YoY
+12.4%
Dividend growth streak
2
Last ex-dividend
2026-08-17

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
8.0%
Trailing 12 months
Net margin
6.6%
Gross profit (TTM)
$68.47M
Operating profit (TTM)
$25.80M
Net income (TTM)
$21.20M
Trailing 12 months
Diluted EPS (TTM)
$0.72
FCF margin
21.7%
Effective tax rate
23.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$10.86
Gross profit per diluted share (TTM)
$2.48
Operating profit per diluted share (TTM)
$0.87
EBITDA per diluted share (TTM)
$2.38
Net income per diluted share (TTM)
$0.72
Operating cash flow per diluted share (TTM)
$2.43
Free cash flow per diluted share (TTM)
$2.36
Capital expenditures per diluted share (TTM)
$0.07
R&D per diluted share (TTM)
$1.83
Stock compensation per diluted share (TTM)
$0.29
Book value per share
$11.97

Growth

11 metrics
Revenue growth YoY
+12.5%
Year over year
Net income growth YoY
+23.8%
Revenue (TTM)
$321.12M
Trailing 12 months
EPS growth YoY
+27.8%
Shares change YoY
-3.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.5%
Revenue CAGR (5Y)
+4.4%
EPS CAGR (3Y)
+16.1%
EPS CAGR (5Y)
+6.8%
FCF CAGR (3Y)
+6.5%
FCF CAGR (5Y)
+12.0%

Quality

14 metrics
Return on equity
5.9%
Return on assets
4.1%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
$70.30M
Free cash flow (TTM)
$69.83M
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$46.17M
Total assets
$521.60M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$71.79M
Capital expenditures (TTM)
$1.96M
R&D (TTM)
$54.05M
SG&A (TTM)
—
Stock compensation (TTM)
$8.62M
R&D / revenue
16.8%
Stock compensation / revenue
2.7%

Ownership (13F)

9 metrics
13F filers
219
13F filer change QoQ
+21
Institutional ownership
75.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
20.8%
Private-fund adviser ownership
20.4%
Active holders' share change QoQ
-1.3%
Holder tenure
16.1
Price vs estimated holder cost
+8.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.6%

Short interest

3 metrics
Short interest
4.3%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.67M
Insider-sentiment score
22 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1095565 CUSIP 42222N103 13F (30d) 44 filings 39 filers Visit website Investor relations